课题基金 / 基金详情

项目摘要

项目成果

RANDALL F HOLCOMBE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Chediak-Higashi syndrome (CHS) is a rare immuno-deficiency disease with manifestations involving alterred hemostasis, an increase in the frequency of malignancies, abnormal function of lysosomes with resultant lack of "Natural Killer" activity, and an increase in a specific subset of T-lymphocytes. The gene responsible for the syndrome has not been characterized in either the human or murine system, although the chromosomal location of the gene causing the analogous syndrome in mice (bg) has been identified. The goals of this project are: 1) Generate a murine "jumping library" to identify new probes close to bg, 2) Define restriction fragment length polymorphisms (RFLP) with these probes through cross hybridization with human DNA, 3) Determine genetic linkage of the probes to the CHS gene by RFLP and family analysis, 4) analyze human and murine northern blots to identify transcripts of the putative gene and 5) sequence putative CHS genes and predict the protein product. The technology for identifying a gene by "reverse genetics" on the basis of its chromosomal location exists and should be facilitated in this instance by the presence of an animal model for which the gene has been previously mapped. Identification of the CHS gene should provide information about hemostasis, immune surveillance, lysosomal function, and the in vivo function of gamma delta T-lymphocytes. Dr. Randall Holcombe is completing training in the medical subspecialties of hematology and oncology and has already initiated a productive research program concerning CHS. He has developed expertise in the molecular biological techniques required for the successful completion of the research program described herein over the prior two years. The Department of Genetics, where the bulk of the research will be performed, has the equipment necessary for recombinant DNA research, with tissue culture and animal facilities. The Hematology Division and the Department of Genetics sponsor journal clubs, lab meetings, and several lecture series, and provide an exciting and stimulating environment for research.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Chronic myelomonocytic leukemia transformation in polycythemia vera.
慢性粒单核细胞白血病转化为真性红细胞增多症。
DOI: --
发表时间: 1991
期刊: Leukemia
影响因子: 11.4
作者: [Holcombe,RF, Treseler,PA, Rosenthal,DS]
通讯作者: Rosenthal,DS
Linkage of loci associated with two pigment mutations on mouse chromosome 13.
与小鼠 13 号染色体上两个色素突变相关的基因座的连锁。
DOI: 10.1017/s0016672300029591
发表时间: 1991
期刊: Genetical research
影响因子: --
作者: [Holcombe,RF, Stephenson,DA, Zweidler,A, Stewart,RM, Chapman,VM, Seidman,JG]
通讯作者: Seidman,JG
Mechanisms of calcium antagonist-induced vasodilation.
钙拮抗剂诱导血管舒张的机制。
DOI: 10.1146/annurev.pa.23.040183.002105
发表时间: 1983
期刊: Annual review of pharmacology and toxicology
影响因子: 12.5
作者: [Cauvin,C, Loutzenhiser,R, VanBreemen,C]
通讯作者: VanBreemen,C
Lysosomal enzyme activities in Chediak-Higashi syndrome: evaluation of lymphoblastoid cell lines and review of the literature.
Chediak-Higashi 综合征中的溶酶体酶活性:类淋巴母细胞系的评估和文献综述。
DOI: --
发表时间: 1994
期刊: Immunodeficiency
影响因子: --
作者: [Holcombe,RF, Jones,KL, Stewart,RM]
通讯作者: Stewart,RM
Neoadjuvant photodynamic immunomodulation for colon cancer
  • 批准号:
    8005456
  • 项目类别:
  • 资助金额:
    $29.82万
  • 财政年份:
    2010
  • 负责人:
    RANDALL F HOLCOMBE
  • 依托单位:
Neoadjuvant photodynamic immunomodulation for colon cancer
  • 批准号:
    8119595
  • 项目类别:
  • 资助金额:
    $30.21万
  • 财政年份:
    2010
  • 负责人:
    RANDALL F HOLCOMBE
  • 依托单位:
PHASE I BIOMARKER STUDY OF DIETARY GRAPE-DERIVED LOW DOSE RESVERATROL FOR COLON
PHASE I BIOMARKER STUDY OF DIETARY GRAPE-DERIVED LOW DOSE RESVERATROL FOR COLON
海外基金